Qureshi, Z., Jamil, A., Okobi, T. J., Amankwah, M. (2025). Predictive value of PIK3CA mutations for response to CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer: A systematic review and meta-analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e13025